gph.covid19vaccinejanssen.com Open in urlscan Pro
2606:4700::6812:dc8  Public Scan

Form analysis
0 forms found in the DOM

Text Content

The information on this page is based on the Emergency Use Listing (EUL) granted
by WHO for COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]). The EUL is
intended to assist UN procurement agencies and Member States in determining the
acceptability of using a specific unlicensed product in the context of a public
health emergency, based on an essential set of available quality, safety, and
efficacy/immunogenicity/ performance data. It is the sole prerogative of
national authorities to decide whether or not to allow the emergency use of an
unlicensed product in their country or to use the EUL as the basis for a local
marketing authorisation. If your country is not a WHO Member State, the
information on this page will not be relevant for your country.


COVID-19 Vaccine Janssen
COVID-19 vaccine (Ad26.COV2-S [recombinant])

Select your language
Language...
Submit
عربى English Français Português Español
EM-65333

© Janssen Pharmaceuticals, Inc. 2021. All Rights Reserved.

Your use of the information on this site is subject to the terms of our Legal
Notice. Please see our Privacy Policy This site is published by Janssen
Pharmaceuticals, Inc., which is solely responsible for its contents. Capitalized
product names are trademarks of Janssen Pharmaceuticals, Inc. Janssen
Pharmaceuticals, Inc., recognizes that the Internet is a global communications
medium; however, laws, regulatory requirements, and medical practices for
pharmaceutical products vary from country to country.

Information specific to individual countries is identified where it appears.
Last updated June 11, 2021.